Draft:Rasha Abdelsalam Elshenawy

Draft article not currently submitted for review.

This is a draft Articles for creation (AfC) submission. It is not currently pending review. While there are no deadlines, abandoned drafts may be deleted after six months. To edit the draft click on the "Edit" tab at the top of the window.

To be accepted, a draft should:

Show the subject qualifies for a Wikipedia article by using multiple sources that meet four criteria. The sources should be (1) reliable (2) secondary (3) independent of the subject (4) talk about the subject in some depth. For some topics, there are alternative criteria.
Be written from a neutral point of view
Respect copyright and do not plagiarize. Do not copy-paste.

It is strongly discouraged to write about yourself, your business or employer. If you do so, you must declare it.

Where to get help

If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed.

How to improve a draft

Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia.
Help:Wikitext – how to use the markup
Help:Referencing for beginners – how to include references
Wikipedia:Article development – how to develop your article
Wikipedia:Writing better articles – how to improve your article
Wikipedia:Verifiability – make sure your article includes reliable third-party sources

You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article.

Improving your odds of a speedy review

To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

Add tags to your draft

Editor resources

Easy tools: Citation bot (help) | Advanced: Fix bare URLs

Last edited by Asilvering (talk | contribs) 0 seconds ago. (Update)

Submit the draft for review!

Dr. Rasha Abdelsalam Elshenawy is a Consultant of Antimicrobial Resistance at the South Centre, Geneva, Switzerland, and a Senior Lecturer at the University of Hertfordshire, UK. She is widely recognised for her leadership in antimicrobial stewardship and public health.

Early Life and Education

Dr. Rasha Abdelsalam Elshenawy was born on 10 December 1980. She has pursued a rigorous academic and professional education that has solidified her as a global leader in antimicrobial stewardship and pharmacy practice. Her educational journey includes:

PhD in Antimicrobial Stewardship (2020–2024): University of Hertfordshire, UK, focusing on the impact of antimicrobial stewardship before and during the COVID-19 pandemic in acute care settings.
MSc in Clinical Pharmacy (2014): Egyptian Pharmacy Syndicate, Egypt.
Postgraduate Diploma in Healthcare Quality and Accreditation (2014–2016): National Association of Healthcare Quality (NAHQ), USA.
Total Quality Management Diploma (2012–2014): American University in Cairo, Egypt (Distinction).
Postgraduate Diploma in Clinical Pharmacy (2009–2011): Cambridge Institute (Distinction).
Added Qualification in Infectious Disease (2018): American Board of Pharmacy Specialties (BPS).
Postgraduate Teaching and Learning Programme (2016–2018): American College of Clinical Pharmacy (ACCP), USA.
Bachelor's Degree in Pharmaceutical Sciences (1997–2002): Tanta University, Egypt.

Throughout her academic career, Dr. Elshenawy has acquired skills in clinical research, data analysis, evidence-based medicine, stewardship, and quality improvement. Her education has been instrumental in shaping her contributions to global health and antimicrobial resistance strategies.

Career

Dr. Rasha Abdelsalam Elshenawy has an extensive career in pharmacy practice, academic leadership, and antimicrobial stewardship. Her roles span multiple organisations and reflect her expertise in education, research, and clinical practice:

**Senior Lecturer** (2024–present): University of Hertfordshire, UK. Dr. Elshenawy is responsible for delivering advanced teaching and learning experiences within the School of Life and Medical Sciences. Her role includes supervising Master of Public Health students, leading modules on pharmacovigilance, and integrating innovative digital teaching methods. She also contributes to impactful research and promotes interprofessional collaboration across diverse teams.
**Antimicrobial Resistance Consultant** (2024–present): South Centre, Geneva, Switzerland. Dr. Elshenawy advises on antimicrobial resistance strategies, focusing on sustainable solutions and global health collaboration.
**Chief Executive Officer** (2015–present): FADIC Clinical Pharmacy Development, UK. As the CEO, she oversees strategic, operational, and financial management of the organisation, driving growth and fostering innovation in pharmacy education and practice.
**Director of Antimicrobial Stewardship School** (2014–present): Dr. Elshenawy leads antimicrobial education and research initiatives, including the development of stewardship strategies and teaching undergraduate and postgraduate students.
**Antimicrobial Stewardship Research Fellow** (2021–2023): Bedfordshire Hospitals NHS Foundation Trust, UK. During her tenure, she conducted research on the WHO AWaRe classification of antibiotics and led studies focusing on antimicrobial use before and during the COVID-19 pandemic.
**Visiting Lecturer** (2023–2024): University of Hertfordshire, UK. Dr. Elshenawy delivered high-quality teaching and conducted Objective Structured Clinical Examinations (OSCE) assessments for students in the School of Life and Medical Sciences.
**Antimicrobial Stewardship Lead** (2015–2019): Security Forces Hospital, Saudi Arabia. She established a comprehensive antimicrobial stewardship programme, developed hospital-wide policies, and improved antibiotic prescribing practices.

Dr. Elshenawy’s career highlights her commitment to advancing antimicrobial stewardship and enhancing global pharmacy practices through education, research, and leadership.

Research and Publications

Dr. Rasha Abdelsalam Elshenawy has made significant contributions to antimicrobial stewardship, antibiotic prescribing practices, and public health research, particularly during the COVID-19 pandemic. Her research outputs span peer-reviewed articles, conference presentations, and posters, focusing on combating antimicrobial resistance and promoting sustainable pharmacy practices. Key publications and presentations include:

R. A. Elshenawy (10 February 2023). "Antimicrobial stewardship implementation before and during the COVID-19 pandemic in the acute care settings: a systematic review". BMC Public Health. [Available online](https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-15463-3). Retrieved: 1 January 2025.

R. A. Elshenawy (11 December 2023). "WHO AWaRe classification for antibiotic stewardship: tackling antimicrobial resistance – a descriptive study from an English NHS Foundation Trust prior to and during the COVID-19 pandemic". *Frontiers in Microbiology*. Volume 14, Section Antimicrobials, Resistance and Chemotherapy. doi:10.3389/fmicb.2023.1298858. [Available online](https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1298858/full). Retrieved: 1 January 2025.

R. Elshenawy et al. (8 November 2024). "Healthcare workers' views on antibiotic prescribing and stewardship during the COVID-19 pandemic at an NHS Foundation Trust in England: a cross-sectional survey". *International Journal of Pharmacy Practice*. 32: ii39–ii40. doi:10.1093/ijpp/riae058.047. ISSN 0961-7671. [Available online](https://academic.oup.com/ijpp/article/32/Supplement_2/ii39/7885418). Retrieved: 1 January 2025.

R. Elshenawy (20 February 2024). "How pharmacists can contribute to effective antimicrobial reviews". *The Pharmaceutical Journal*. [Available online](https://pharmaceutical-journal.com/article/ld/how-pharmacists-can-contribute-to-effective-antimicrobial-reviews). Retrieved: 1 January 2025.

R. A. Elshenawy (23 April 2024). "Novel survey distribution methods: impact on antimicrobial resistance research outcomes". *JAC-Antimicrobial Resistance*. 6 (2): dlae055. doi:10.1093/jacamr/dlae055. [Available online](https://academic.oup.com/jacamr/article/6/2/dlae055/7656711). Retrieved: 1 January 2025.

R. A. Elshenawy (18 November 2024). "Enhancing Antimicrobial Resistance Surveillance in Hospitals in Developing Countries: Overcoming Challenges and Bridging Data Gaps". *The South Centre World Antibiotic Awareness Event*. Switzerland. [Available online](https://www.southcentre.int/webinar-enhancing-antimicrobial-resistance-surveillance-in-developing-countries-18-november-2024/). Retrieved: 1 January 2025.

R. A. Elshenawy et al. (8 November 2024). "Trends in antibiotic use in a UK secondary care prior to and during the COVID-19 pandemic: a cross-sectional retrospective study". *International Journal of Pharmacy Practice*. 32 (Supplement_2): ii37–ii38. doi:10.1093/ijpp/riae058.045. ISSN 0961-7671. [Available online](https://academic.oup.com/ijpp/article/32/Supplement_2/ii37/7885435#google_vignette). Retrieved: 1 January 2025.

R. A. Elshenawy et al. (8 November 2024). "The FIP Global Roadmap 2030: Sustainable Pharmacy and Antimicrobial Stewardship with a Novel Antibiotic Dashboard". *Royal Pharmaceutical Society Annual Conference 2024: Working Across Boundaries: Embracing New Opportunities and Empowering Excellence*. London, United Kingdom. [Available online](https://researchprofiles.herts.ac.uk/en/publications/the-fip-global-roadmap-2030-sustainable-pharmacy-and-antimicrobia). Retrieved: 1 January 2025.

R. A. Elshenawy (3 October 2024). "An Urgent Call for Sustainable Stewardship: Confronting the Global Burden of Bacterial Antimicrobial Resistance with Forecasts to 2050". Microbiology, Protocols & Methods, and Pharmacy & Pharmacology. [Available online](https://communities.springernature.com/posts/an-urgent-call-for-sustainable-stewardship-confronting-the-global-burden-of-bacterial-antimicrobial-resistance-with-forecasts-to-2050). Retrieved: 1 January 2025.

R. A. Elshenawy (23 August 2024). "UKHSA Start Smart Then Focus antimicrobial stewardship: effective implementation during the COVID-19 pandemic at an NHS Foundation Trust in the UK". JAC-Antimicrobial Resistance. 6 (Supplement_2): dlae136.004. doi:10.1093/jacamr/dlae136.004. [Available online](https://academic.oup.com/jacamr/article/6/Supplement_2/dlae136.004/7738642). Retrieved: 1 January 2025.

R. A. Elshenawy, N. Umaru, & Z. Aslanpour (2024). "Protocol to Investigate Factors Impacting Antimicrobial Stewardship Implementation Before and During COVID-19 in Two Acute Care Settings". Protocols.io, 34 pages. [Available online](https://uhra.herts.ac.uk/handle/2299/27868). Retrieved: 1 January 2025.

Dr. Elshenawy’s research highlights the critical role of antimicrobial stewardship in healthcare and provides actionable insights for combating antibiotic resistance globally. Her work has been recognised in both academic and professional forums, making her a thought leader in the field.

Research and Publications

Awards and Recognition

Professional Memberships

References